State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Minnesota, Missouri, Mississippi

Key briefs were filed this week in state contract pharmacy litigation in Minnesota, Missouri and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Magic Johnson-Backed Startup Raises $31 Million to Help Build, Expand In-House Pharmacies at 340B HIV Clinics

Alchemy announced that it has raised $31 million, as part of a campaign with NBA legend Earvin “Magic” Johnson, to help build in-house pharmacies for HIV clinics. (Credit: Shutterstock)
A California-based healthcare startup recently announced that it has raised more than $30 million, as part of a campaign with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’

Joe Grogan (left), a top official in the former Trump administration raised serious concerns with the 340B program during the keynote address at The Association for Value-Based Cancer Care Annual Summit in New York Thursday.
A key official in the former Trump administration raised serious concerns with the 340B program during the keynote address at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended

J&J's proposed rebate model was a key topic of discussion at a Wednesday panel led by moderator, 340B Report Publisher and CEO Ted Slafsky.
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Centers Urge Federal Appeals Court to Take Their Side in Case Alleging Drug Manufacturer Collusion on Contract Pharmacy Restrictions

Two community health centers argued in a Sept. 30 filing with the U.S. 2nd Circuit Court of Appeals that diabetes drugmakers colluded to place contract pharmacy restrictions.
Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

FQHCs Reinvest 340B Savings in Safety-Net Care, JAMA Study Finds

Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new study in JAMA Health Forum.
Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Orders and Filings in Arkansas, Louisiana, Kansas, Mississippi Maryland, Missouri

Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Announces Specialty Pharmacy Senderra No Longer Eligible to Dispense Asthma Drug

GSK headquarters
Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.
Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen Announces NDC Change for Osteoporosis Drug

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.
Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Praise Federal Court’s Defense of Louisiana Contract Pharmacy Law as Drug Industry Weighs Next Steps

A federal court upheld Louisiana’s contact pharmacy law this week, drawing praise from provider groups and criticism from the drug industry in the latest of such challenges across the nation.
A key federal court decision to uphold Louisiana’s contact pharmacy law this week is drawing praise from provider groups and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live